Facebook
Twitter
Telegram
Report an ErrorMerrimack Pharmaceuticals Balance Sheet 2011-2024 | MACK
Annual Balance Sheet Merrimack Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -14 M | -16.6 M | 46 M | -93.4 M | 195 M | 72 M | 84.5 M | 46.6 M | 2.14 M | -50.4 M |
Long Term Debt |
- | - | - | - | - | 14.9 M | - | 217 M | 258 M | 107 M | 103 M | 37.5 M | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | 13.3 M | 8.25 M | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 14.9 M | 1.26 M | 244 M | 315 M | 150 M | 178 M | 117 M | 349 M |
Total Current Liabilities |
441 K | 589 K | 562 K | 770 K | 2.77 M | 14.8 M | 19.8 M | 88.2 M | 104 M | 111 M | 57.7 M | 38.5 M | - |
Total Liabilities |
441 K | 589 K | 562 K | 770 K | 2.77 M | 29.7 M | 21 M | 333 M | 419 M | 261 M | 236 M | 155 M | 375 M |
Deferred Revenue |
- | - | - | - | - | - | - | 36.2 M | 50.1 M | 59.3 M | 9.34 M | 10.2 M | 7.84 M |
Retained Earnings |
-549 M | -548 M | -546 M | -544 M | -541 M | -523 M | -483 M | -955 M | -802 M | -655 M | -572 M | -442 M | -351 M |
Total Assets |
19.2 M | 19.8 M | 14.7 M | 16.8 M | 20.1 M | 88.5 M | 117 M | 81.5 M | 235 M | 159 M | 192 M | 149 M | 85.3 M |
Cash and Cash Equivalents |
5.99 M | 19.4 M | 14.2 M | 14 M | 16.6 M | 20.1 M | 93.4 M | 21.5 M | 186 M | 35.7 M | 65.1 M | 37.7 M | 50.5 M |
Book Value |
18.7 M | 19.2 M | 14.2 M | 16 M | 17.3 M | 58.8 M | 96.3 M | -251 M | -184 M | -102 M | -43.5 M | -6.52 M | -290 M |
Total Shareholders Equity |
18.7 M | 19.2 M | 14.2 M | 16 M | 17.3 M | 58.8 M | 96.3 M | -251 M | -184 M | -102 M | -43.5 M | -6.52 M | -290 M |
All numbers in USD currency
Quarterly Balance Sheet Merrimack Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15 M | 15 M | 15 M | - | - | - | 49.9 M | 48.9 M | 218 M | 217 M | 217 M | 217 M | 217 M | 258 M | 258 M | 258 M | 258 M | 107 M | 107 M | 107 M | 107 M | 103 M | 103 M | 103 M | 103 M | 37.5 M | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
22.7 M | 441 K | 493 K | 411 K | 463 K | 589 K | 448 K | - | 564 K | 562 K | 683 K | 772 K | 684 K | 770 K | 770 K | 770 K | 770 K | 2.77 M | 2.77 M | 2.77 M | 2.77 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 21 M | 21 M | 21 M | 21 M | 334 M | 334 M | 334 M | 334 M | 419 M | 419 M | 419 M | 419 M | 261 M | 261 M | 261 M | 261 M | 236 M | 236 M | 236 M | 236 M | 155 M | 155 M | 155 M | 155 M | 107 M | 107 M | 107 M | 107 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 36.2 M | 36.6 M | 44.2 M | 45.1 M | 50.1 M | 50.1 M | 50.1 M | 50.1 M | 59.3 M | 59.3 M | 59.3 M | 59.3 M | 9.34 M | 9.34 M | 9.34 M | 9.34 M | 9.35 M | 9.35 M | 9.35 M | 9.35 M | 7.71 M | 7.71 M | 7.71 M | 7.71 M |
Retained Earnings |
-347 M | -549 M | -549 M | -548 M | -548 M | -548 M | -547 M | - | -546 M | -546 M | -546 M | -545 M | -544 M | -544 M | -544 M | -544 M | -544 M | -541 M | -541 M | -541 M | -541 M | -523 M | -523 M | -523 M | -523 M | -483 M | -483 M | -483 M | -483 M | -955 M | -955 M | -955 M | -955 M | -802 M | -802 M | -802 M | -802 M | -655 M | -655 M | -655 M | -655 M | -572 M | -572 M | -572 M | -572 M | -442 M | -442 M | -442 M | -442 M | -351 M | -351 M | -351 M | -351 M |
Total Assets |
244 M | 19.2 M | 19.3 M | 19.4 M | 19.6 M | 19.8 M | 13.6 M | - | 14.6 M | 14.7 M | 15.3 M | 15.9 M | 16.4 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 88.5 M | 88.5 M | 88.5 M | 88.5 M | 117 M | 117 M | 117 M | 117 M | 81.5 M | 81.5 M | 81.5 M | 81.5 M | 235 M | 235 M | 235 M | 235 M | 159 M | 159 M | 159 M | 159 M | 192 M | 192 M | 192 M | 192 M | 149 M | 149 M | 149 M | 149 M | 85.3 M | 85.3 M | 85.3 M | 85.3 M |
Cash and Cash Equivalents |
234 M | 5.99 M | 6.08 M | 10.1 M | 19.4 M | 19.4 M | 13.1 M | 13.4 M | 14.3 M | 14.2 M | 14.6 M | 14.9 M | 13.9 M | 14 M | 14 M | 14 M | 14 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 93.4 M | 93.4 M | 93.4 M | 93.4 M | 21.5 M | 21.5 M | 21.5 M | 21.5 M | 186 M | 186 M | 186 M | 186 M | 35.7 M | 35.7 M | 35.7 M | 35.7 M | 65.1 M | 65.1 M | 65.1 M | 65.1 M | 37.7 M | 37.7 M | 37.7 M | 37.7 M | 50.5 M | 50.5 M | 50.5 M | 50.5 M |
Book Value |
222 M | 18.7 M | 18.8 M | 19 M | 19.2 M | 19.2 M | 13.2 M | - | 14.1 M | 14.2 M | 14.6 M | 15.1 M | 15.8 M | 16 M | 16 M | 16 M | 16 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 58.8 M | 58.8 M | 58.8 M | 58.8 M | 96.3 M | 96.3 M | 96.3 M | 96.3 M | -253 M | -253 M | -253 M | -253 M | -184 M | -184 M | -184 M | -184 M | -102 M | -102 M | -102 M | -102 M | -43.1 M | -43.1 M | -43.1 M | -43.1 M | -6.42 M | -6.42 M | -6.42 M | -6.42 M | -21.7 M | -21.7 M | -21.7 M | -21.7 M |
Total Shareholders Equity |
222 M | 18.7 M | 18.8 M | 19 M | 19.2 M | 19.2 M | 13.2 M | 13.6 M | 14.1 M | 14.2 M | 14.6 M | 15.1 M | 15.8 M | 16 M | 16 M | 16 M | 16 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 58.8 M | 58.8 M | 58.8 M | 58.8 M | 96.3 M | 96.3 M | 96.3 M | 96.3 M | -251 M | -251 M | -251 M | -251 M | -184 M | -184 M | -184 M | -184 M | -102 M | -102 M | -102 M | -102 M | -43.5 M | -43.5 M | -43.5 M | -43.5 M | -6.52 M | -6.52 M | -6.52 M | -6.52 M | -290 M | -290 M | - | -290 M |
All numbers in USD currency